ABINASH P ACHREKAR

Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease ALBUQUERQUE, NM NPI 1669431201

General Payments — all program years on this page

$120,641.24

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 274
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $1,586.44 across 18 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $986.4417
Consulting Fee $600.001

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $33,643.4294
2019 $51,468.2374
2020 $16,563.5735
2021 $8,346.5015
2022 $4,391.6715
2023 $4,641.4123
2024 $1,586.4418

Records — PY2024 (18)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1086698661 Novartis Pharmaceuticals Corporation $1.26 03/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086698669 Novartis Pharmaceuticals Corporation $16.70 07/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086698671 Novartis Pharmaceuticals Corporation $136.83 05/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086698677 Novartis Pharmaceuticals Corporation $0.24 04/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086698679 Novartis Pharmaceuticals Corporation $2.56 04/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086698681 Novartis Pharmaceuticals Corporation $11.31 04/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096706971 Novo Nordisk Inc $116.03 05/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097828958 Novo Nordisk Inc $125.23 10/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101756299 E.R. Squibb & Sons, L.L.C. $68.95 02/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101756423 E.R. Squibb & Sons, L.L.C. $600.00 05/08/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1104209629 AstraZeneca Pharmaceuticals LP $112.23 03/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1132061662 PFIZER INC. $120.59 03/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1132062672 PFIZER INC. $17.16 05/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1132063482 PFIZER INC. $13.44 02/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135994692 Lilly USA, LLC $28.92 06/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136008913 Lilly USA, LLC $19.92 12/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1138832092 Edwards Lifesciences Corporation $179.52 05/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154051959 iRhythm Technologies, Inc. $15.55 06/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.